Equities

Diagnos Inc

ADK:CVE

Diagnos Inc

Actions
TechnologyTechnology
  • Price (CAD)0.31
  • Today's Change0.01 / 3.33%
  • Shares traded15.00k
  • 1 Year change+8.77%
  • Beta-0.4569
Data delayed at least 15 minutes, as of Apr 19 2024 15:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ADK:CVE price moved over +8.33% to 0.325
  • ADK:CVE price rises above 15-day moving average to 0.315 at 10:48 BST
  • ADK:CVE price falls below 15-day moving average to 0.29 at 11:56 BST

Key statistics

As of last trade, Diagnos Inc (ADK:CVE) traded at 0.31, 34.78% above the 52 week low of 0.23 set on Mar 28, 2024.
52-week range
Today
0.23Mar 28 20240.590Sep 08 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.315
High0.32
Low0.31
Bid0.305
Offer0.31
Previous close0.300
Average volume76.95k
Shares outstanding76.65m
Free float65.74m
P/E (TTM)--
Market cap22.99m CAD
EPS (TTM)-0.0425
CAD
Data delayed at least 15 minutes, as of Apr 19 2024 15:27 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.